Crestchem Ltd
₹ 125
0.00%
25 Apr
2:54 p.m.
About
Incorporated in 1991, Crestchem Ltd is primarily into manufacturing Nutrition- Chemical Products.
Key Points
- Market Cap ₹ 37.5 Cr.
- Current Price ₹ 125
- High / Low ₹ 145 / 58.4
- Stock P/E 24.0
- Book Value ₹ 11.1
- Dividend Yield 0.00 %
- ROCE 37.4 %
- ROE 28.7 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 34.0%
Cons
- Stock is trading at 11.2 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding is low: 32.1%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0.12 | 0.09 | 0.42 | 0.09 | 0.13 | 0.14 | 0.05 | 0.10 | 6.15 | 7.62 | 7.90 | 16.66 | 18.50 | |
0.27 | 0.26 | 0.36 | 0.23 | 0.18 | 0.34 | 0.29 | 0.26 | 5.59 | 6.95 | 7.15 | 15.84 | 16.55 | |
Operating Profit | -0.15 | -0.17 | 0.06 | -0.14 | -0.05 | -0.20 | -0.24 | -0.16 | 0.56 | 0.67 | 0.75 | 0.82 | 1.95 |
OPM % | -125.00% | -188.89% | 14.29% | -155.56% | -38.46% | -142.86% | -480.00% | -160.00% | 9.11% | 8.79% | 9.49% | 4.92% | 10.54% |
0.28 | 0.22 | 0.03 | 0.89 | 0.19 | 0.08 | 0.03 | 0.02 | 0.03 | 0.05 | 0.08 | 0.15 | 0.22 | |
Interest | 0.00 | 0.04 | 0.03 | 0.02 | 0.02 | 0.04 | 0.01 | 0.01 | 0.00 | 0.02 | 0.02 | 0.01 | 0.00 |
Depreciation | 0.09 | 0.09 | 0.08 | 0.05 | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 | 0.02 | 0.03 | 0.02 | 0.03 |
Profit before tax | 0.04 | -0.08 | -0.02 | 0.68 | 0.12 | -0.16 | -0.22 | -0.16 | 0.57 | 0.68 | 0.78 | 0.94 | 2.14 |
Tax % | 0.00% | 0.00% | 0.00% | 10.29% | 25.00% | 0.00% | 13.64% | 0.00% | 22.81% | 14.71% | 26.92% | 26.60% | |
0.04 | -0.08 | -0.03 | 0.61 | 0.09 | -0.16 | -0.19 | -0.17 | 0.44 | 0.57 | 0.57 | 0.69 | 1.56 | |
EPS in Rs | 0.13 | -0.27 | -0.10 | 2.03 | 0.30 | -0.53 | -0.63 | -0.57 | 1.47 | 1.90 | 1.90 | 2.30 | 5.19 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | 69% |
5 Years: | 220% |
3 Years: | 39% |
TTM: | 5% |
Compounded Profit Growth | |
---|---|
10 Years: | 17% |
5 Years: | 41% |
3 Years: | 16% |
TTM: | 75% |
Stock Price CAGR | |
---|---|
10 Years: | 26% |
5 Years: | 53% |
3 Years: | 46% |
1 Year: | 7% |
Return on Equity | |
---|---|
10 Years: | 16% |
5 Years: | 32% |
3 Years: | 34% |
Last Year: | 29% |
Balance Sheet
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 |
Reserves | -2.49 | -2.57 | -2.59 | -2.09 | -2.00 | -2.16 | -2.36 | -2.53 | -2.08 | -1.51 | -0.94 | -0.25 | 0.33 |
0.26 | 0.30 | 0.40 | 0.37 | 0.35 | 0.60 | 0.14 | 0.28 | 0.02 | 0.63 | 0.27 | 0.00 | 0.00 | |
0.24 | 0.29 | 0.49 | 0.22 | 0.05 | 0.05 | 0.04 | 0.14 | 1.35 | 0.87 | 0.96 | 2.04 | 3.82 | |
Total Liabilities | 1.01 | 1.02 | 1.30 | 1.50 | 1.40 | 1.49 | 0.82 | 0.89 | 2.29 | 2.99 | 3.29 | 4.79 | 7.15 |
0.63 | 0.54 | 0.46 | 0.04 | 0.04 | 0.04 | 0.11 | 0.12 | 0.10 | 0.14 | 0.11 | 0.10 | 0.20 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
0.38 | 0.48 | 0.84 | 1.46 | 1.36 | 1.45 | 0.71 | 0.77 | 2.19 | 2.85 | 3.18 | 4.69 | 6.95 | |
Total Assets | 1.01 | 1.02 | 1.30 | 1.50 | 1.40 | 1.49 | 0.82 | 0.89 | 2.29 | 2.99 | 3.29 | 4.79 | 7.15 |
Cash Flows
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-0.27 | -0.16 | -0.10 | 0.05 | -0.27 | -0.04 | -0.70 | -0.02 | 0.33 | 0.39 | 0.82 | 2.21 | |
0.27 | 0.19 | 0.02 | 0.06 | 0.34 | 0.64 | 0.12 | 0.01 | -0.35 | -0.39 | -0.83 | -1.34 | |
0.00 | -0.02 | 0.07 | -0.05 | -0.02 | -0.04 | -0.01 | -0.01 | 0.00 | -0.02 | -0.02 | -0.01 | |
Net Cash Flow | 0.00 | 0.01 | -0.01 | 0.06 | 0.05 | 0.55 | -0.58 | -0.02 | -0.02 | -0.01 | -0.02 | 0.86 |
Ratios
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 212.92 | 121.67 | 356.31 | 0.00 | 336.92 | 469.29 | 730.00 | 292.00 | 71.81 | 67.54 | 41.58 | 0.44 |
Inventory Days | 104.29 | 73.00 | 0.00 | 60.83 | 0.00 | 73.00 | 0.00 | 182.50 | 0.75 | 0.00 | 0.00 | 0.00 |
Days Payable | 521.43 | 219.00 | 60.83 | 73.00 | 365.00 | 91.06 | ||||||
Cash Conversion Cycle | -204.23 | -24.33 | 356.31 | 0.00 | 336.92 | 469.29 | 730.00 | 109.50 | -18.50 | 67.54 | 41.58 | 0.44 |
Working Capital Days | -273.75 | -202.78 | 112.98 | -486.67 | 336.92 | 547.50 | 1,460.00 | 730.00 | 4.75 | 43.11 | 9.70 | -36.81 |
ROCE % | -24.66% | -28.00% | 1.30% | -13.40% | 10.65% | -8.60% | -18.92% | -19.61% | 67.46% | 45.75% | 35.96% | 37.40% |
Documents
Announcements
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 2002
from bse
Business Overview:[1][2]
The company's business comprises manufacturing, processing, marketing, and exporting products derived from Nutraceutical Ingredients from conventional chemical, food, and pharmaceutical fields. The company's products are used in the health food industry like personal care products, and as specialty chemical ingredients.